-

Nitto Acquires Bend Labs, Inc. in the United States

OSAKA, Japan--(BUSINESS WIRE)--Nitto Denko Corporation (headquarter: Osaka, Japan, President: Hideo Takasaki, hereafter Nitto) (TOKYO:6988) and Bend Labs, Inc. (US, Co-CEO: Jared Jonas, Colton Ottley, hereafter "Bend") have agreed on Nitto’s acquisition of Bend. Bend merges into the Nitto Group on June 1, 2022 and starts its business as Nitto Bend Technologies. Hereafter, they will combine Bend’s sensor device technologies with Nitto's strengths to develop next-generation technologies and products, and to develop new businesses which utilize sensor-acquired data.

Nitto develops new products and services by strategically devoting resources to Nitto’s three focus domains: Information Interface, Next-generation Mobility, and Human Life. The acquisition of Bend will also accelerate innovation in these domains.

The flexible sensor developed by Bend simultaneously measures "bend", "stretch" and "force" at high accuracy, in addition to having excellent flexibility and durability. The flexible sensor is expected to meet the evolving technical demands in various fields, including automation in the automotive field and remote monitoring in the digital healthcare field. Through this acquisition, Nitto aims to create new businesses by combining Nitto's global foundation and core technologies, such as adhesive technology and flexible printed circuit technology, with Bend’s sensor device technology.

Besides expected applications in the ever-changing automotive and healthcare fields, Nitto also anticipates these technologies to be utilized in fields such as sports and robotics. Furthermore, Nitto considers building a platform to accumulate sensor-acquired data and deploying services utilizing the acquired data.

Overview of the acquired company:

Former Company Name

Bend Labs, Inc.

New Company Name

Nitto Bend Technologies, Inc.

Location

Farmington, Utah, United States

Year of Establishment

2013

Representatives

Jared Jonas, Colton Ottley

Number of Employees

9

Sales (in FY2021)

5.9M US$

The impact of this acquisition on Nitto's consolidated earnings forecast for FY2022 is insignificant. In case significant effect is recognized, Nitto will report it thereafter.

Contacts

[For any inquiries about this press release]
Aki Kuwabara
Brand Strategy Department, Nitto Denko Corporation
Tel: +81-6-7632-2101/FAX: +81-6-7632-2568

Industry:

Nitto Denko Corporation

TOKYO:6988
Release Versions
EnglishJapanese

Contacts

[For any inquiries about this press release]
Aki Kuwabara
Brand Strategy Department, Nitto Denko Corporation
Tel: +81-6-7632-2101/FAX: +81-6-7632-2568

Social Media Profiles
Nitto on Facebook
Nitto on LinkedIn
More News From Nitto Denko Corporation

Nitto to Launch Counseling System in California, U.S.

OSAKA, Japan--(BUSINESS WIRE)--Nitto Denko Corporation (TOKYO: 6988) (headquartered: Osaka, Japan, President: Hideo Takasaki, hereafter Nitto) announced that it has launched sales of Counseling System in parts of California, United States from September 2024. Counseling System is a service that enables real-time analysis and visualization of a client’s physiological data and feed it back to counselors and psychologists. Counseling System is a service that provides information useful to both the...

Launch of the Nitto ATP Finals Torino Green Project: Our sustainability efforts through sponsorship of the Nitto ATP Finals

OSAKA, Japan--(BUSINESS WIRE)--Nitto Denko Corporation (TOKYO: 6988) (Headquarters: Osaka, Japan; President: Hideo Takasaki) (hereafter "Nitto"), together with the ATP, FITP (Italian Tennis and Padel Federation), and City of Turin, have launched a joint environmental sustainability project as part of its sponsorship of the Nitto ATP Finals, the finale of the ATP Tour season to be held from 12-19 November, 2023. Nitto places ESG (Environment, Society and Governance) at the core of its management...

Nitto Strengthens Oligonucleotide Therapeutic Manufacturing Business

OSAKA, Japan--(BUSINESS WIRE)--In response to the rapid market expansion of oligonucleotide therapeutics that have potential to treat both common and intractable diseases, Nitto Denko Corporation (Headquarters: Osaka; President: Hideo Takasaki; referred to hereafter as “Nitto”) will invest approximately 25 billion Japanese yen in Nitto Denko Avecia Inc. (Headquarters: Massachusetts, USA; referred to hereafter as “Avecia”), a subsidiary of Nitto, and other related business establishments and gro...
Back to Newsroom